Xueyin Wang, Xiaosong Zhang, Juan Juan, Di Gao, Huixia Yang, Meihua Zhang, Xu Chen, Xietong Wang, Yuyan Ma, Yue Teng, Haixia Meng, Xiaoqing Wang, Qiuhong Yang, Lin Xu, Shufan Shan
Journal: Journal of global health 2026;16():04168
PMID: 42171390
BACKGROUND
Maternal haemoglobin (Hb) is a potential biomarker of maternal and neonatal health. Little is known about trimester-specific associations between maternal Hb concentrations and adverse pregnancy outcomes. Here, we assessed the magnitude and shape of these associations and further estimated developmental trajectories of maternal Hb concentrations during pregnancy.
METHODS
In this prospective, observational cohort study, we enrolled pregnant women at 11-13 weeks of gestation from 13 hospitals of northern China between October 2020 and June 2024. We classified maternal Hb concentrations in the first, second, and third trimester (i.e. 11-13, 24-27, and 36-40 weeks' gestation, respectively) into three groups: <110 g/L, 110-129 g/L, and ≥130 g/L, respectively. We used logistic regression models, restricted cubic spline analysis, and group-based trajectory models to examine the association between maternal Hb concentrations and pregnancy outcomes.
RESULTS
Among 10 201 participants, maternal Hb concentrations of ≥130 g/L in the first, second, and third trimester were associated with increased odds of gestational diabetes mellitus and hypertension in pregnancy. Maternal Hb concentrations of <110 g/L in the second trimester were associated with higher odds of postpartum haemorrhage (odds ratio (OR) = 1.38; 95% confidence interval (CI) = 1.04-1.83). Maternal Hb concentrations of ≥130 g/L in the third trimester were associated with higher odds of small-for-gestational-age (OR = 1.48; 95% CI = 1.23-1.79) and low birth weight (OR = 1.55; 95% CI = 1.11-2.16). We further identified a U-shaped relationship between maternal Hb concentrations in the third trimester and small-for-gestational age (P-value for nonlinearity = 0.002). Lastly, high Hb trajectories during pregnancy were associated with higher odds of caesarean delivery (OR = 1.21; 95% CI = 1.10, 1.34), small-for-gestational age (OR = 1.41; 95% CI = 1.16, 1.72) and low birth weight (OR = 1.46; 95% CI = 1.03, 2.05).
CONCLUSIONS
Both higher and lower maternal Hb concentrations were associated with higher odds of adverse pregnancy outcomes. Our findings emphasise the importance of longitudinal monitoring of maternal Hb concentrations throughout pregnancy.
REGISTRATION
ClinicalTrials.gov: NCT04486456.
Copyright © 2026 by the Journal of Global Health. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.